| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018215 Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 01/29/2004 | US20040018177 Vacination method |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492110A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/28/2004 | EP1383919A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383778A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 01/28/2004 | EP1383762A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 01/28/2004 | EP1383751A1 Novel azoles having an insecticidal action |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383504A1 Sustained release drug delivery system containing codrugs |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1136187C 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 01/28/2004 | CN1135974C Antimalarical compound dihydroatremisinin |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683029 Halopyrimidines |
| 01/27/2004 | CA2261095C Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 01/27/2004 | CA2188110C Pesticidal dry powder formulation enriched in azadirachtin upto 88%, an emulsifiable concentrate enriched upto 30% of azadirachtin and a process for preparing such formulation andconcentrate from neem seed/kernel |
| 01/22/2004 | WO2004007478A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor |
| 01/22/2004 | US20040014973 Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines |
| 01/22/2004 | US20040014951 Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A |
| 01/22/2004 | US20040014813 Compositions comprising certain active compounds which are suitable as repellents, and to their use for preventing an infection of humans or of animals by the infectious stages of parasitic flatworms (platyhelminths). |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014781 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/22/2004 | US20040014740 Compound containing sulfur containing ring; parasiticides |
| 01/22/2004 | US20040014708 Composition comprising immunogenic microparticles |
| 01/22/2004 | US20040014689 Endoparaciticidal and ectoparasiticidal agents |
| 01/22/2004 | US20040014661 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 01/22/2004 | US20040013739 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 01/22/2004 | US20040013727 Hydrophilic gel foaming matrix; cellulose ethers |
| 01/22/2004 | US20040013699 Antiprotozoa agents; swine; veterinary medicine |
| 01/22/2004 | US20040013671 Diagnosis, therapy of infections using labeled antibody |
| 01/22/2004 | CA2492330A1 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/21/2004 | EP1382603A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381374A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel |
| 01/21/2004 | EP1257265B1 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 01/21/2004 | EP1242415B1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 01/21/2004 | EP1229791B1 Active ingredient combination having insecticidal and acaricidal characteristics |
| 01/21/2004 | EP1165573B1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
| 01/21/2004 | EP1126852B1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 01/21/2004 | CN1469868A Use of triazinetrione sulfones for combating coccidiosis |
| 01/21/2004 | CN1469865A Pyrazole derivatives for the treatment of viral diseases |
| 01/21/2004 | CN1469754A Orally administered peptides to ameliorate a therosclerosis |
| 01/21/2004 | CN1469747A Use of triazinetrione sulfoxides for controlling coccidioses |
| 01/21/2004 | CN1468625A Neem oil prepn for preventing and treating parasitic disease of aquatic animals and its prepn process |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/21/2004 | CN1135225C Preparation and application of pesticidal enantiomer-pure 2,4-disubstituted oxazolines |
| 01/20/2004 | US6680333 Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/20/2004 | US6680308 Administering n-(formyl or acetyl)-n-hydroxylamino)-alkylphosphonic acid derivative as viricide, parasiticide or fungicide |
| 01/20/2004 | US6680306 Method for enhancing the effectiveness of cancer therapies |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004004778A1 Use of cetp inhibitors and optionally hmg coa reductable inhibitors and/or antihypertensive agents |
| 01/15/2004 | WO2004004713A1 Fredericamycin derivatives as medicaments for treating tumours |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | WO2002072010A3 Taxane prodrugs |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010025 Substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa |
| 01/15/2004 | US20040010016 Control of arthropods in animals |
| 01/15/2004 | US20040010007 Also thio, sulfoxy and sulfonyl derivatives; imidazotetrazolopyrimidines and intermediates |
| 01/15/2004 | US20040009992 Azolylalkylazole derivatives, their preparation, and their use as pesticides |
| 01/15/2004 | US20040009930 Macrolide antibiotics |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009551 Comprises nucleotide sequences coding peptide antibiotic for treatment of parasitic infection and cell proliferative disorders |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009123 Methylenediphosphonate derivatives containing one or two hydroxy groups, useful for treating parasitosis and autoimmune maldy in primate |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2488736A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 01/14/2004 | EP1380208A1 Disinfectant agent with antiparasitic activity |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379138A1 Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 01/14/2004 | CN1468235A Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/14/2004 | CN1468220A New piperidine derivatives |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468093A Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/13/2004 | CA2112811C Continuous cell line and vaccine against avian coccidia |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 01/08/2004 | WO2004002537A1 Worming formulation |
| 01/08/2004 | WO2004002527A1 Compositions against chicken coccidiosis |
| 01/08/2004 | WO2002091996A3 Methods for treating cancer |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |